Continuing advanced therapies before elective Crohn's surgery may reduce serious complications
Patients with Crohn's disease who continue advanced therapies, including biologics and small-molecule drugs, in the months before elective colorectal surgery may have a lower risk of two postoperative complications: anastomotic leak and organ space surgical site infection, according to a study published in the Journal of the American College of Surgeons.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.